It’s being expected that by 2030, the Corneal Implants market cap will hit $ 767.50 million at a CAGR growth of about 6.9%.
The global corneal implants market was valued at USD 374.9 million in 2019. Increase in prevalence of eye disorders such as corneal blindness, Fuchs’ dystrophy, along with rapidly growing geriatric patient pool and supportive government initiatives to control vision loss are key factors driving the global corneal implants market.
Corneal implants, also known as corneal inlays or intracorneal implants are becoming more common as a treatment for corneal ectasia. Corneal implants are small fragments of rings or complete rings of silicone transplant type that are inserted in the corneal stroma to normalize corneal surface topography, increase contact lens tolerability, and preserve vision acuity in order to postpone or avoid the need for corneal transplantation. Corneal blindness has a complex epidemiology that includes a wide range of infectious and inflammatory eye diseases that cause corneal scarring, which contributes to functional blindness. According to WHO, there are currently 146 million people living with trachoma worldwide, of which 10 million have trichiasis and need surgery to prevent corneal blindness. Moreover, around 4.9 million are totally blind due to trachomatous corneal scarring. Moreover, rapidly growing elderly patient pool is at high risk of developing ophthalmic disorders. All these factors are expected to boost the growth of corneal implants market in the next few years.
The global corneal implants market has been segmented based on type, transplant type, application, end-users, and region. Based on type, the global corneal implants market is categorized into human cornea and synthetic. Human cornea segment held the largest share of global market in 2019. On the basis of transplant type, the global corneal implants market is segmented into penetrating keratoplasty, and endothelial keratoplasty. Penetrating keratoplasty segment dominated the global corneal implants market in 2019. Geographically, North America dominated the global corneal implants market in 2019, however, Asia Pacific is expected to be the fastest growing region by 2028.
Key players operating in the global corneal implants market include AJL Ophthalmic SA, Florida Lions Eye Bank, CorneaGen, San Diego Eye Bank, Alcon Inc., Aurolab, KeraMed, Inc., Massachusetts Eye and Ear, Alabama Eye Bank Inc., and DIOPTEX among others.
Corneal Implants Market Scope
Metrics | Details |
Base Year | 2023 |
Historic Data | 2018-2022 |
Forecast Period | 2024-2030 |
Study Period | 2018-2030 |
Forecast Unit | Value (USD) |
Revenue forecast in 2030 | US$ 767.50 Million |
Growth Rate | CAGR of 6.9% during 2020-2030 |
Segment Covered | Type, Transplant Type, Application, End-users, Regions |
Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
Key Players Profiled | AJL Ophthalmic SA, Florida Lions Eye Bank, CorneaGen, San Diego Eye Bank, Alcon Inc., Aurolab, KeraMed, Inc., Massachusetts Eye and Ear, Alabama Eye Bank Inc., and DIOPTEX among others. |
Key Segments of the Global Corneal Implants Market
Type Overview, (USD Million)
- Human Cornea
- Synthetic
Transplant Type Overview, (USD Million)
- Penetrating Keratoplasty
- Endothelial Keratoplasty
Application Overview,(USD Million)
- Keratoconus
- Fungal Keratitis
- Fuchs Dystrophy
- Others
End-users Overview, (USD Million)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Regional Overview, (USD Million)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Reasons for the study
- Increase in prevalence of coneal disorders
- Surging geriatric population across the globe
What does the report include?
- The study on the global corneal implants market includes qualitative insights such as drivers, restraints, challenges and opportunities
- Additionally, the market has been evaluated using the Porter’s Five Forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of type, transplant type, application, end-users, and region.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players operating in the market
Who should buy this report?
- The report on the global corneal implants market is suitable for all the players across the value chain including raw material suppliers, hospitals & clinics, medical device manufacturers, healthcare organizations, ophthalmologists, distributors, suppliers and technology geeks
- Venture capitalists and investors looking for more information on the future outlook of the global corneal implants market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global corneal implants market
Frequently Asked Questions (FAQ) :
Implant placement is a minimally invasive procedure that is normally done in an outpatient setting under topical anesthesia by corneal specialists or refractive surgeons. The implants are reversible and flexible, and they do not interfere with corneal transplantation or limit the efficiency of subsequent surgical approaches. Surging elderly patient pool suffering from age-related ophthalmic disorders is expected to drive the global corneal implants market. Furthermore, the presence of organizations such as the Eye Bank Association of America (EBAA) and The Global Alliance of Eye Bank Associations, which advocate for policies that encourage successful corneal transplantation will have a positive impact on industry growth.
The global corneal implants market has been segmented based on type, transplant type, application, end-users, and region. Based on type, the global corneal implants market is categorized into human cornea, and synthetic cornea. Human cornea segment held substantial share of the global market in 2019. High awareness about corneal transplants and eye tissue donation in developed countries along with better success rate of human cornea are major factors anticipated to drive the segment growth.
Based on transplant type, the global the global corneal implants market is segmented into penetrating keratoplasty and endothelial keratoplasty. Penetrating keratoplasty segment grabbed majority of the market share in 2019. Endothelial keratoplasty offers many advantages over full-thickness penetrating keratoplasty. These benefits include quicker vision recovery, less operating time, limited corneal tissue removal resulting in less effects on the eye's structural integrity and vulnerability to injury, no associated suture complications, and a lower risk of astigmatism following surgery. All these factors are anticipated to drive the growth of the segment in the coming years.
Application-wise, the global corneal implants market is segregated into keratoconus, fungal keratitis, Fuchs dystrophy, and others. Increase in prevalence of Fuchs’ dystrophy is expected to propel the growth of the segment in the coming years. Based on end-users, the global corneal implants market is categorized into hospitals, specialty clinics, and ambulatory surgical centers. Hospitals accounted for majority of the market share in 2019.
The global corneal implants market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global corneal implants market in 2019, however Asia Pacific is expected to grow at a rapid pace through 2028.
Higher prevalence of corneal vision loss and higher adoption of penetrating keratoplasty in the U.S. is a major factor expected to drive the growth of the market in the region. It is estimated that, approximately 10 million people in the U.S. suffer from corneal vision loss and around 40,000 transplants are performed each year in the country. Furthermore, presence of large elderly patient population, coupled with strong foothold of key industry players and eye banks are other major factors likely to boost the growth of the market in North America.
However, Asia Pacific is expected to grow at a rapid pace over the next few years. There is a strong growth potential in the emerging economies such as India, and China. The rapidly rising geriatric population in countries such as India and China, increase in prevalence of ocular diseases along with high unmet clinical needs provide large market for corneal implants. According to estimates, India will have 10.6 million cases of unilateral corneal blindness by the year 2020 which is further anticipated to boost the growth of the market in the coming years.